Spiro Rombotis
2017
In 2017, Spiro Rombotis earned a total compensation of $776K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 6% increase compared to previous year.
Compensation breakdown
| Bonus | $185,694 |
|---|---|
| Option Awards | $22,467 |
| Salary | $530,553 |
| Other | $37,310 |
| Total | $776,024 |
Rombotis received $530.6K in salary, accounting for 68% of the total pay in 2017.
Rombotis also received $185.7K in bonus, $22.5K in option awards and $37.3K in other compensation.
Rankings
In 2017, Spiro Rombotis' compensation ranked 10,161st out of 14,666 executives tracked by ExecPay. In other words, Rombotis earned more than 30.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,161 out of 14,666 | 31st |
Division Manufacturing | 3,935 out of 5,772 | 32nd |
Major group Chemicals And Allied Products | 1,383 out of 2,075 | 33rd |
Industry group Drugs | 1,123 out of 1,731 | 35th |
Industry Pharmaceutical Preparations | 878 out of 1,333 | 34th |
Source: SEC filing on April 12, 2018.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2017.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020